Indeed, we found several chemokines previously described to promote LSC growth in CML-BM, such as CCL-3, CCL-4, and TNF-α to be expressed in the splenic microenvironment and produced by RPMs in CML. The gene discussed is CCL3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.